2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk.

Task Force, Members; Committee for Practice Guidelines (CPG), ESC; National Cardiac Societies, ESC (2019). 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk. Atherosclerosis, 290, pp. 140-205. Elsevier 10.1016/j.atherosclerosis.2019.08.014

[img] Text
1-s2.0-S0021915019314595-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (6MB)

Item Type:

Journal Article (Review Article)

Division/Institute:

04 Faculty of Medicine > Department of Cardiovascular Disorders (DHGE) > Clinic of Cardiology

ISSN:

0021-9150

Publisher:

Elsevier

Language:

English

Submitter:

Nadia Biscozzo

Date Deposited:

08 Dec 2020 16:57

Last Modified:

11 Dec 2020 01:28

Publisher DOI:

10.1016/j.atherosclerosis.2019.08.014

PubMed ID:

31591002

Additional Information:

Konstantinos C. Koskinas: Task Force
Stephan Windecker: ESC Committee for Practice Guidelines (CPG)

Uncontrolled Keywords:

Apolipoprotein B Cholesterol; Dyslipidaemias Familial hypercholesterolaemia Guidelines High-density lipoproteins Lipoprotein remnants Lipoprotein(a) Low-density lipoproteins Total cardiovascular risk Treatment (adherence) Treatment (drugs) Treatment (lifestyle) Triglycerides Very low-density lipoproteins

BORIS DOI:

10.7892/boris.149346

URI:

https://boris.unibe.ch/id/eprint/149346

Actions (login required)

Edit item Edit item
Provide Feedback